Freeline Therapeutics Holdings Plc (FRLN) Stock
FRLN is no longer traded. Freeline Therapeutics Holdings Plc was delisted from the Nasdaq in February 2024.
Prices on this page are historical; the last trade was February 15, 2024 at $6.48.
Freeline Therapeutics Holdings Plc stock price history
FRLN final trading statistics
- Final close
- $6.48
- Final trading day
- Feb 15, 2024
- Market cap at delisting
- $28.24M
- Shares outstanding
- 4.36M
- Final 52-week range
- $0.23 – $8.70
- Avg. volume (final 3 mo.)
- 28,147
- All-time high (split-adj.)
- $274.50 · Dec 2020
- All-time low (split-adj.)
- $2.22 · Jun 2023
- Return since IPO
- -97.6%
- Beta
- 0.66
- Book value / share
- $6.89
- Price / book
- 0.94
Freeline Therapeutics Holdings Plc annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $622.0K | -$49.9M | — |
| FY2022 | $617.0K | -$89.0M | -$1.73 |
| FY2021 | $0.00 | -$140.4M | -$3.92 |
| FY2020 | $0.00 | -$96.3M | -$15.30 |
| FY2019 | $0.00 | -$53.9M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Freeline Therapeutics Holdings Plc
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.
Freeline Therapeutics Holdings Plc stock FAQ
What happened to Freeline Therapeutics Holdings Plc stock?
Freeline Therapeutics Holdings Plc stock was delisted from the Nasdaq. Its final close was $6.48 on February 15, 2024.
Is FRLN stock still trading?
No. FRLN was delisted from the Nasdaq in February 2024 and no longer trades on a U.S. exchange.
What was the last price of FRLN stock?
FRLN closed at $6.48 on its final trading day, February 15, 2024, for a market value of about $28.24M.
What were Freeline Therapeutics Holdings Plc's revenue and earnings in its last full fiscal year?
Freeline Therapeutics Holdings Plc reported revenue of $622.0K and net income of -$49.9M in fiscal 2023, its last full year as a public company.
When did Freeline Therapeutics Holdings Plc go public?
Freeline Therapeutics Holdings Plc stock began trading on August 7, 2020.